Gabexate mesylate
CAS No. | 56974-61-9 | Cat. No. | BCP13557 |
Name | Gabexate mesylate | ||
Synonyms | FOY;Gabexate Mesilate; | ||
Formula | C17H27N3O7S | M. Wt | 417.48 |
Description | Gabexate mesylate is a non-antigenic synthetic inhibitor of trypsin-like serine proteinases that is therapeutically used in the treatment of pancreatitis and disseminated intravascular coagulation and as a regional anticoagulant for hemodialysis. Values of the inhibition constant (K(i)) for gabexate mesylate binding to human and bovine tryptase were 3.4 x 10(-9) M and 1.8 x 10(-7) M (at pH 7.4 and 37.0 degrees ), respectively. Gabexate mesylate inhibited the fibrinogenolytic activity of human tryptase. Gabexate Mesylate decreased the TNFalpha production of LPS-stimulated monocytes as shown by the inhibition of mRNA expression and increased the IL-10 production of LPS-stimulated monocytes. Gabexate Mesylate also suppressed the NFkappaB activity of LPS-stimulated monocytes. Inhibitory effect of Gabexate Mesylate on the TNFalpha production of activated human monocytes is mediated by the suppression of NFkappaB activation . Gabexate mesylate inhibits competitively constitutive and inducibl | ||
Pathways | Protease/Metabolic Enzyme | ||
Targets | Serine Protease Proteasome Factor Xa |
Structure
![](https://img.biochemsafebuy.com/uploads/img/56974-61-9_BCP13557.png)
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.